Legal opinion from Beijing Zhonglun (Chengdu) Law Firm regarding the adjustment of the grant price of the 2023 restricted stock incentive plan, the achievement of the conditions for the third vesting period, and the cancellation of part of the restricted stock by Yili Chuaning Biotechnology Co., Ltd.